Literature DB >> 16842386

Risk perception in drug therapy.

J K Aronson.   

Abstract

Mesh：

Year:  2006        PMID： 16842386      PMCID： PMC1885091          DOI： 10.1111/j.1365-2125.2006.02739_1.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  Consumer perceptions of risk and required cost savings for generic prescription drugs.

Authors:  J M Ganther; D H Kreling
Journal:  J Am Pharm Assoc (Wash)       Date:  2000 May-Jun

2.  Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs.

Authors:  J J Davis
Journal:  J Health Commun       Date:  2000 Oct-Dec

Review 3.  Explaining risks: turning numerical data into meaningful pictures.

Authors:  Adrian Edwards; Glyn Elwyn; Al Mulley
Journal:  BMJ       Date:  2002-04-06

4.  How can doctors communicate information about risk more effectively?

Authors:  Andy Alaszewski; Tom Horlick-Jones
Journal:  BMJ       Date:  2003-09-27

5.  Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals.

Authors:  V Bongard; S Ménard-Taché; H Bagheri; K Kabiri; M Lapeyre-Mestre; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

6.  The importance of news media in pharmaceutical risk communication: proceedings of a workshop.

Authors:  Felicia E Mebane
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-05       Impact factor: 2.890

Review 7.  Clarification of terminology in drug safety.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

8.  Communicating information about drug safety.

Authors:  R E Ferner; J K Aronson
Journal:  BMJ       Date:  2006-07-15

9.  General practitioners' ranking of evidence-based prescribing quality indicators: a comparative study with a prescription database.

Authors:  Ifeanyi Okechukwu; Kathleen Bennett; John Feely
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

10.  Patients' knowledge of adverse reactions to current medications.

Authors:  Garret Cullen; Emer Kelly; Frank E Murray
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335
View more
  12 in total

1.  Patients' Preferences for Generic and Branded Over-the-Counter Medicines: An Adaptive Conjoint Analysis Approach.

Authors:  Merja Halme; Kari Linden; Kimmo Kääriä
Journal:  Patient       Date:  2009-12-01       Impact factor: 3.883

2.  Adverse drug reactions--no farewell to harms.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

3.  An agenda for research on adverse drug reactions.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2007-08       Impact factor: 4.335

Review 4.  A strategy for regulatory action when new adverse effects of a licensed product emerge.

Authors:  Jeffrey K Aronson; Deirdre Price; Robin E Ferner
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

5.  Adverse drug reaction monitoring of antidepressants in the psychiatry outpatients department of a tertiary care teaching hospital.

Authors:  Swati Mishra; Trupti Rekha Swain; Manjushree Mohanty
Journal:  J Clin Diagn Res       Date:  2013-06-01

6.  Adverse drug reaction monitoring in psychiatry out-patient department of an Indian teaching hospital.

Authors:  Gairik Sengupta; Subhrojyoti Bhowmick; Avijit Hazra; Ananya Datta; Musfikur Rahaman
Journal:  Indian J Pharmacol       Date:  2011-02       Impact factor: 1.200

7.  Medication Risk Management.

Authors:  A K Mohiuddin
Journal:  Innov Pharm       Date:  2019-08-31

8.  Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising.

Authors:  Bridget J Kelly; Douglas J Rupert; Kathryn J Aikin; Helen W Sullivan; Mihaela Johnson; Carla M Bann; Nicole Mack; Brian G Southwell; Sue West; Sarah Parvanta; Alexander Rabre; Susana Peinado
Journal:  Res Social Adm Pharm       Date:  2020-08-06

9.  Perception of teratogenic and foetotoxic risk by health professionals: a survey in Midi-Pyrenees area.

Authors:  Christine Damase-Michel; Juliette Pichereau; Atul Pathak; Isabelle Lacroix; Jean Louis Montastruc
Journal:  Pharm Pract (Granada)       Date:  2008-03-10

10.  Spontaneous adverse drug reaction reporting by patients in Canada: a multi-method study-study protocol.

Authors:  Rania Al Dweik; Sanni Yaya; Dawn Stacey; Dafna Kohen
Journal:  Springerplus       Date:  2016-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.